BioNTech SE (BNTX)
92.45
+0.17
(+0.18%)
USD |
NASDAQ |
May 15, 14:25
BioNTech Price: 92.45 for May 15, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 14, 2024 | 92.79 | 93.22 | 91.71 | 92.28 | 271443.0 |
May 13, 2024 | 92.56 | 93.48 | 92.41 | 92.72 | 249384.0 |
May 10, 2024 | 92.59 | 93.38 | 91.53 | 91.67 | 389880.0 |
May 09, 2024 | 90.24 | 93.86 | 90.14 | 92.06 | 581680.0 |
May 08, 2024 | 90.72 | 90.99 | 89.38 | 90.13 | 343979.0 |
May 07, 2024 | 92.85 | 93.23 | 90.75 | 90.88 | 487803.0 |
May 06, 2024 | 90.09 | 95.29 | 89.94 | 93.35 | 1.098M |
May 03, 2024 | 93.42 | 93.54 | 91.60 | 92.72 | 663327.0 |
May 02, 2024 | 90.75 | 92.40 | 90.68 | 92.24 | 561841.0 |
May 01, 2024 | 86.77 | 90.66 | 86.36 | 89.95 | 426983.0 |
Apr 30, 2024 | 88.39 | 89.62 | 87.87 | 88.82 | 410420.0 |
Apr 29, 2024 | 87.01 | 89.53 | 87.01 | 87.95 | 409261.0 |
Apr 26, 2024 | 87.40 | 88.32 | 86.89 | 87.21 | 355731.0 |
Apr 25, 2024 | 87.98 | 88.24 | 86.13 | 86.71 | 438099.0 |
Apr 24, 2024 | 88.59 | 89.45 | 87.82 | 88.09 | 281679.0 |
Apr 23, 2024 | 88.08 | 89.52 | 87.58 | 88.49 | 362446.0 |
Apr 22, 2024 | 86.88 | 88.72 | 86.50 | 88.01 | 528474.0 |
Apr 19, 2024 | 85.70 | 87.59 | 85.62 | 86.81 | 1.578M |
Apr 18, 2024 | 85.67 | 86.77 | 85.60 | 86.17 | 578632.0 |
Apr 17, 2024 | 86.63 | 86.88 | 85.40 | 86.40 | 1.265M |
Apr 16, 2024 | 86.44 | 87.32 | 86.14 | 86.34 | 782142.0 |
Apr 15, 2024 | 86.12 | 88.96 | 86.06 | 87.89 | 753281.0 |
Apr 12, 2024 | 86.69 | 86.79 | 85.60 | 86.48 | 726723.0 |
Apr 11, 2024 | 89.64 | 89.64 | 86.81 | 87.01 | 574536.0 |
Apr 10, 2024 | 88.53 | 89.39 | 87.61 | 88.65 | 429437.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
12.75
Minimum
Oct 14 2019
447.23
Maximum
Aug 09 2021
130.44
Average
111.88
Median
Jan 08 2024
Price Benchmarks
Pfizer Inc | 28.84 |
Moderna Inc | 128.60 |
Novavax Inc | 12.70 |
GSK PLC | 45.76 |
BioVie Inc | 0.4969 |
Price Related Metrics
PE Ratio | 192.41 |
PS Ratio | 7.523 |
Price to Book Value | 1.033 |
Price to Free Cash Flow | 4.158 |
Earnings Yield | 0.52% |
Market Cap | 22.28B |
Normalized PE Ratio | 134.04 |